Stay updated on BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Sign up to get notified when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6, replacing the previous v3.6.5 on the study record.
    Difference
    0.1%
    Check dated 2026-09-01T20:55:53.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the ClinicalTrials.gov page was published. This appears to be a minor update or correction rather than a change to the study data or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-08-11T22:06:28.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4. This indicates a minor page refresh or metadata update on the study details page without altering the study information.
    Difference
    0.1%
    Check dated 2026-07-21T12:50:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The revision label on the page updated to v3.6.3, replacing the previous v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-30T00:55:34.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The study record now shows recruitment has ended, indicating the trial is not enrolling any more participants. Added navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a site revision label (Revision: v3.6.0); the header formatting around Intervention/Treatment was updated.
    Difference
    0.6%
    Check dated 2026-06-15T19:00:44.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This indicates a behind-the-scenes update to the study page's software or content management system.
    Difference
    0.1%
    Check dated 2026-06-08T15:24:22.000Z thumbnail image

Stay in the know with updates to BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.